The surge in geriatric population across the globe, growing consumer awareness of orthobiologics, rise in demand for advanced treatment, rise in obesity, and the growing number of sports and road accidents drive the growth of the global orthobiologics market.
Orthopedic insoles have the potential to revolutionize the lives of individuals dealing with posture issues, foot pain, spinal concerns, flat feet, and various locomotor irregularities. The worldwide demand for orthotic insoles is propelled by several factors, including the growing population of those experiencing foot discomfort, an uptick in osteoporosis cases among middle-aged women, and the increasing adoption of technologically advanced products.
A recently published study by Fact.MR suggests that the global gene therapy market is projected to grow at a compound annual growth rate (CAGR) of 18.5% from 2022 to 2032, reaching a valuation of US$10.1 billion. By 2022, the market is expected to reach a value of US$1.85 billion. The increasing pursuit of breakthroughs in medical treatments has driven the demand for gene therapy across various grades.
